Pharvaris (PHVS) EBT (2020 - 2026)
Pharvaris' (PHVS) quarterly EBT came in at -$45.6 million in Q1 2026, up 5.89% YoY from -$43.0 million in Q1 2025, and up 13.14% on a QoQ basis from -$52.5 million in Q4 2025.
Pharvaris (PHVS) EBT (2020 - 2026) Analysis & Trends
Pharvaris (PHVS) has 7 years of EBT data on file, last reported at -$45.6 million in Q1 2026.
- Quarterly EBT rose 5.89% year-over-year to -$45.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$192.9 million (down 19.28% YoY) and the FY2025 annual result came in at -$196.3 million, down 36.96% from the prior year.
- EBT rose to -$45.6 million in Q1 2026, from -$52.5 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$10.5 million in Q2 2022 to a low of -$52.5 million in Q4 2025.
- A 5-year average of -$33.8 million and a median of -$35.6 million in 2023 frame the typical range for EBT.
- The widest YoY moves for EBT: up 42.41% in 2022, down 146.94% in 2022.
- Tracing PHVS's EBT over 5 years: stood at -$40.4 million in 2022, then increased by 11.77% to -$35.6 million in 2023, then declined by 0.56% to -$35.8 million in 2024, then slumped by 46.48% to -$52.5 million in 2025, then rose by 13.14% to -$45.6 million in 2026.
- The last three EBT figures came in at -$45.6 million (Q1 2026), -$52.5 million (Q4 2025), and -$43.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Pharvaris | 2.29 Bn | 1.92 Bn | - | -54.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.87 Mn |
| Mar 31, 2026 | -45.57 Mn |
| Dec 31, 2025 | -52.47 Mn |
| Sep 30, 2025 | -43.63 Mn |
| Jun 30, 2025 | -51.25 Mn |
| Mar 31, 2025 | -48.43 Mn |
| Dec 31, 2024 | -35.82 Mn |
| Sep 30, 2024 | -45.55 Mn |
| Jun 30, 2024 | -31.94 Mn |
| Mar 31, 2024 | -30.13 Mn |
| Dec 31, 2023 | -35.62 Mn |
| Sep 30, 2023 | -25.53 Mn |
| Jun 30, 2023 | -23.74 Mn |
| Mar 31, 2023 | -24.23 Mn |
| Dec 31, 2022 | -40.37 Mn |
| Sep 30, 2022 | -10.98 Mn |
| Jun 30, 2022 | -10.54 Mn |
| Mar 31, 2022 | -17.94 Mn |
| Dec 31, 2021 | 34,662.07 Bn |
| Sep 30, 2021 | -10.70 Mn |